Diphtheria and Tetanus Antitoxoids

Overview

  • EPIC Code:
  • IMO412
  • Soft Test Code:
  • TETA1
  • Send Out Test Code:
  • 34042
Alternate Names
  • Former Name: Tetanus and Diptheria Toxoid IgG Anti
  • Tetanus/Dip IgG
Included Tests

Diphtheria Antitoxoid; Tetanus Antitoxoid


Clinical Significance

Used to evaluate diphtheria immunization response. Antibody levels of > or = to 0.10 IU/mL are considered protective. For Pre and Post vaccination testing to assess normal immune response

Tetanus is caused by Clostridium tetani. Immunization with Tetanus Antitoxoid is effective with boosters in immunocompetent individuals. Antibody levels of > or = to 0.10 IU/mL are considered protective. However, tetanus can still occur in some individuals with such antibody levels. These results should not be used to determine the necessity to administer antitoxin when clinically indicated. For Pre and Post vaccination testing to assess normal immune response, please refer to Test Code 91424, Tetanus Antitoxoid, Pre and Post Vaccination


Specimen Collection & Preparation

Specimen Requirements

2.0 mL Serum from a Red Top Tube in each of 2 Plastic Vials

Alternate Specimen

2.0 mL Serum from a SST Gold Top Tube

TransportAndStorage

7 days Ambient (transport)
14 days Refrigerated
30 days Frozen

Collection Instructions

Serum must be separated equally into two separate Plastic vials with 2 mls in each. 

Clinical Interpretation

Reference Range:

Diphtheria Antitoxoid ≥0.10 IU/mL
Tetanus Antitoxoid ≥0.10 IU/mL


Methodology:
  • Enzyme Immunoassay (EIA)

Clinical Significance

Used to evaluate diphtheria immunization response. Antibody levels of > or = to 0.10 IU/mL are considered protective. For Pre and Post vaccination testing to assess normal immune response

Tetanus is caused by Clostridium tetani. Immunization with Tetanus Antitoxoid is effective with boosters in immunocompetent individuals. Antibody levels of > or = to 0.10 IU/mL are considered protective. However, tetanus can still occur in some individuals with such antibody levels. These results should not be used to determine the necessity to administer antitoxin when clinically indicated. For Pre and Post vaccination testing to assess normal immune response, please refer to Test Code 91424, Tetanus Antitoxoid, Pre and Post Vaccination


Production Schedule

Sites Performed
  • Quest - Chantilly
Days Performed
Tuesday
Thursday
Saturday
Departments
  • Sendouts - Clinical
Turn Around Time

1 to 4 days


Coding & Compliance

CDM

00913333


CPT Coding

86648, 86774